Publication:
The Global HIV Epidemics among People Who Inject Drugs

dc.contributor.authorDutta, Arin
dc.contributor.authorWirtz, Andrea
dc.contributor.authorStanciole, Anderson
dc.contributor.authorOelrichs, Robert
dc.contributor.authorSemini, Iris
dc.contributor.authorBaral, Stefan
dc.contributor.authorPretorius, Carel
dc.contributor.authorHaworth, Caroline
dc.contributor.authorHader, Shannon
dc.contributor.authorBeyrer, Chris
dc.contributor.authorCleghorn, Farley
dc.date.accessioned2013-01-30T20:42:15Z
dc.date.available2013-01-30T20:42:15Z
dc.date.issued2013-01
dc.description.abstractThis publication addresses research questions related to an increase in the levels of access and utilization for four key interventions that have the potential to significantly reduce HIV infections among People Who Inject Drugs (PWID) and their sexual and injecting partners, and hence morbidity and mortality in low and middle-income countries (LMIC). These interventions are drawn from nine consensus interventions that comprise a 'comprehensive package' for PWID. The four interventions are: Needle and Syringe Programs (NSP), Medically Assisted Therapy (MAT), HIV Counseling and Testing (HCT), and Antiretroviral Therapy (ART). The book summarizes the results from several recent reviews of studies related to the effectiveness of the four key interventions in reducing risky behaviors in the context of transmitting or acquiring HIV infection. Overall, the four key interventions have strong effects on the risk of HIV infection among PWID via different pathways, and this determination is included in the documents proposing the comprehensive package of interventions. In order to attain the greatest effect from these interventions, structural issues must be addressed, especially the removal of punitive policies targeting PWID in many countries. The scientific evidence presented here, the public health rationale, and the human rights imperatives are all in accord: we can and must do better for PWID. The available tools are evidence-based, right affirming, and cost effective. What are required now are political will and a global consensus that this critical component of global HIV can no longer be ignored and under-resourced.en
dc.identifierhttp://documents.worldbank.org/curated/en/2012/11/17014790/global-hiv-epidemics-among-people-inject-drugs
dc.identifier.doi10.1596/978-0-8213-9776-3
dc.identifier.isbn978-0-8213-9776-3
dc.identifier.urihttps://hdl.handle.net/10986/12215
dc.languageEnglish
dc.language.isoen_US
dc.publisherWashington, DC: World Bank
dc.relation.ispartofseriesDirections in Development;
dc.rightsCC BY 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo
dc.subjectABSTINENCE
dc.subjectABUSES
dc.subjectACCESS TO TREATMENT
dc.subjectACQUIRED IMMUNODEFICIENCY SYNDROME
dc.subjectADULT POPULATION
dc.subjectAIDS DEATHS
dc.subjectAIDS EPIDEMIC
dc.subjectANTENATAL CLINIC
dc.subjectARVS
dc.subjectBACTERIAL INFECTIONS
dc.subjectBEHAVIORAL INTERVENTIONS
dc.subjectBEHAVIORAL RISK
dc.subjectBEHAVIORAL SURVEILLANCE
dc.subjectCOMMERCIAL SEX
dc.subjectCONDOM
dc.subjectCONDOM DISTRIBUTION
dc.subjectCONDOM USE
dc.subjectCONDOMS
dc.subjectCRIME
dc.subjectDEMOGRAPHIC PROJECTIONS
dc.subjectDEVELOPING COUNTRIES
dc.subjectDISEASE
dc.subjectDISEASE BURDEN
dc.subjectDISEASE CONTROL
dc.subjectDISEASE PREVALENCE
dc.subjectDRUG ADDICTION
dc.subjectDRUG INJECTION
dc.subjectDRUG TREATMENT
dc.subjectDRUG USER
dc.subjectDRUGS
dc.subjectENDOCARDITIS
dc.subjectEPIDEMIC
dc.subjectEPIDEMICS
dc.subjectEPIDEMIOLOGICAL SITUATION
dc.subjectEPIDEMIOLOGY
dc.subjectFEMALE
dc.subjectFEMALE SEX WORKERS
dc.subjectGENDER
dc.subjectGLOBAL AIDS EPIDEMIC
dc.subjectGLOBAL CONSENSUS
dc.subjectGLOBAL HIV/AIDS
dc.subjectGLOBAL POLICY
dc.subjectHEALTH SYSTEMS
dc.subjectHEPATITIS
dc.subjectHEROIN USE
dc.subjectHIGH-RISK GROUPS
dc.subjectHIV
dc.subjectHIV EPIDEMICS
dc.subjectHIV INFECTION
dc.subjectHIV INFECTIONS
dc.subjectHIV PREVALENCE
dc.subjectHIV PREVENTION
dc.subjectHIV TEST
dc.subjectHIV TESTING
dc.subjectHIV TRANSMISSION
dc.subjectHIV/AIDS
dc.subjectHUMAN DEVELOPMENT
dc.subjectHUMAN IMMUNODEFICIENCY VIRUS
dc.subjectHUMAN RIGHTS
dc.subjectIMMUNODEFICIENCY
dc.subjectINCIDENCE OF HIV
dc.subjectINFECTIONS AMONG ADULTS
dc.subjectINJECTING DRUG USE
dc.subjectINJECTION DRUG
dc.subjectINJECTION DRUG USE
dc.subjectINVESTMENT IN PREVENTION
dc.subjectLACK OF INFORMATION
dc.subjectLEGAL STATUS
dc.subjectMALARIA
dc.subjectMALE SEX
dc.subjectMEDICINE
dc.subjectMORBIDITY
dc.subjectMORBIDITY & MORTALITY
dc.subjectMORBIDITY AND MORTALITY
dc.subjectMOTHER
dc.subjectMOTHER-TO-CHILD
dc.subjectMOTHER-TO-CHILD TRANSMISSION
dc.subjectNATIONAL AIDS
dc.subjectNATIONAL AIDS CONTROL
dc.subjectNATIONAL PLANS
dc.subjectNEEDLE EXCHANGE
dc.subjectNEEDLE SHARING
dc.subjectNEEDLES
dc.subjectNEW INFECTIONS
dc.subjectNUMBER OF NEW INFECTIONS
dc.subjectNUTRITION
dc.subjectPATIENT
dc.subjectPATIENTS
dc.subjectPEOPLE LIVING WITH HIV
dc.subjectPOLICY ANALYSIS
dc.subjectPOLICY IMPLICATIONS
dc.subjectPOLITICAL SUPPORT
dc.subjectPOPULATION ESTIMATES
dc.subjectPOPULATION GROUPS
dc.subjectPOPULATION SIZE
dc.subjectPREVALENCE
dc.subjectPREVENTION ACTIVITIES
dc.subjectPREVENTION AND CARE
dc.subjectPUBLIC HEALTH
dc.subjectQUALITY OF LIFE
dc.subjectREHABILITATION
dc.subjectRESOURCE ALLOCATIONS
dc.subjectRIGHTS PERSPECTIVE
dc.subjectRISK BEHAVIOR
dc.subjectRISK BEHAVIORS
dc.subjectRISK OF HIV TRANSMISSION
dc.subjectRISK OF INFECTION
dc.subjectRISK POPULATIONS
dc.subjectRISK REDUCTION
dc.subjectRISK-REDUCTION
dc.subjectRISKY BEHAVIOR
dc.subjectRISKY BEHAVIORS
dc.subjectRISKY SEXUAL BEHAVIOR
dc.subjectSAFE SEX
dc.subjectSCIENTIFIC EVIDENCE
dc.subjectSERVICE DELIVERY
dc.subjectSERVICES FOR PEOPLE
dc.subjectSEX
dc.subjectSEX PRACTICES
dc.subjectSEX WITH MEN
dc.subjectSEX WORKER
dc.subjectSEXUAL CONTACT
dc.subjectSEXUAL NETWORKS
dc.subjectSEXUAL PARTNERS
dc.subjectSEXUAL PRACTICES
dc.subjectSEXUAL RISK
dc.subjectSEXUAL RISK BEHAVIOR
dc.subjectSEXUAL RISK BEHAVIORS
dc.subjectSEXUAL TRANSMISSION
dc.subjectSEXUALLY TRANSMITTED INFECTION
dc.subjectSOCIAL MARKETING
dc.subjectSOCIAL VULNERABILITY
dc.subjectSPREAD OF HIV
dc.subjectSTERILE INJECTION EQUIPMENT
dc.subjectSTERILE SYRINGES
dc.subjectSUBSTANCE ABUSE
dc.subjectSURVEILLANCE DATA
dc.subjectSYRINGES
dc.subjectT-CELL
dc.subjectTB
dc.subjectTHERAPY
dc.subjectTREATMENT
dc.subjectTREATMENT ACCESS
dc.subjectTREATMENT SERVICES
dc.subjectTUBERCULOSIS
dc.subjectUNAIDS
dc.subjectUNEMPLOYMENT
dc.subjectUNIVERSAL ACCESS
dc.subjectUNSAFE INJECTION
dc.subjectUNSAFE SEX
dc.subjectUSER FEES
dc.subjectVIRAL LOAD
dc.subjectVIRUS
dc.subjectVOLUNTARY COUNSELING
dc.subjectWAR
dc.subjectWORLD HEALTH ORGANIZATION
dc.titleThe Global HIV Epidemics among People Who Inject Drugsen
dspace.entity.typePublication
okr.crosscuttingsolutionareaGender
okr.crossref.titleThe Global HIV Epidemics among People Who Inject Drugs
okr.date.disclosure2012-11-29
okr.date.doiregistration2025-04-15T10:54:35.866163Z
okr.doctypePublications & Research::Publication
okr.doctypePublications & Research::Publication
okr.docurlhttp://documents.worldbank.org/curated/en/2012/11/17014790/global-hiv-epidemics-among-people-inject-drugs
okr.globalpracticeHealth, Nutrition, and Population
okr.guid226001468339540607
okr.identifier.doi10.1596/978-0-8213-9776-3
okr.identifier.externaldocumentum000425962_20121129122515
okr.identifier.internaldocumentum17014790
okr.identifier.report74052
okr.language.supporteden
okr.pdfurlhttp://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2012/11/29/000425962_20121129122515/Rendered/PDF/NonAsciiFileName0.pdfen
okr.peerreviewAcademic Peer Review
okr.topicHealth, Nutrition and Population::HIV AIDS
okr.topicHealth, Nutrition and Population::Population Policies
okr.topicDisease Control and Prevention
okr.topicPrivate Sector Development::HIV AIDS and Business
okr.topicGender::Gender and Health
okr.topicHealth
okr.topicNutrition and Population
okr.unitHealth, Nutrition & Popultn Team (HDNHE)
okr.volume1 of 1
relation.isSeriesOfPublication706db16a-e556-46f0-8283-1b4a4b88645c
relation.isSeriesOfPublication.latestForDiscovery706db16a-e556-46f0-8283-1b4a4b88645c
Files
Original bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
NonAsciiFileName0.pdf
Size:
5.56 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
NonAsciiFileName0.txt
Size:
323.22 KB
Format:
Plain Text
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: